72 related articles for article (PubMed ID: 27422973)
1. Safety and efficacy of a hydroxypropyl guar/polyethylene glycol/propylene glycol-based lubricant eye-drop in patients with dry eye.
Labetoulle M; Messmer EM; Pisella PJ; Ogundele A; Baudouin C
Br J Ophthalmol; 2017 Apr; 101(4):487-492. PubMed ID: 27422973
[TBL] [Abstract][Full Text] [Related]
2. Multi-symptom Relief with Propylene Glycol-Hydroxypropyl-Guar Nanoemulsion Lubricant Eye Drops in Subjects with Dry Eye Disease: A Post-Marketing Prospective Study.
Bickle K; Miller JR; Tauber J; Awisi-Gyau D
Ophthalmol Ther; 2024 Feb; 13(2):481-494. PubMed ID: 38079084
[TBL] [Abstract][Full Text] [Related]
3. Safe and Effective Management of Dry Eye Symptoms with Hydroxypropyl Guar and Hyaluronic Acid Dual-Polymer Lubricating Eye Drops: A Review of Preclinical and Clinical Studies.
Srinivasan S; Garofalo R; Williams R
Clin Ophthalmol; 2023; 17():3883-3898. PubMed ID: 38105908
[TBL] [Abstract][Full Text] [Related]
4. Homoeopathic eye drops in the treatment of mild-to-moderate dry eye disease: Randomised, prospective, multicentre, single-masked study.
Mortemousque B; Pisella PJ; Salaun N; Lemaire N; Chanel I
Eur J Ophthalmol; 2023 Dec; ():11206721231216129. PubMed ID: 38062637
[TBL] [Abstract][Full Text] [Related]
5. Squeezability of eye drop containers used in dry eye disease management.
Bitton E; Bouskila J
Clin Exp Optom; 2024 Jun; ():1-6. PubMed ID: 38858843
[TBL] [Abstract][Full Text] [Related]
6. A randomized, controlled study of the efficacy and safety of a new eyedrop formulation for moderate to severe dry eye syndrome.
Chiambaretta F; Doan S; Labetoulle M; Rocher N; Fekih LE; Messaoud R; Khairallah M; Baudouin C;
Eur J Ophthalmol; 2017 Jan; 27(1):1-9. PubMed ID: 27445067
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of an oil-based lubricant eyedrop in dry eye patients with lipid deficiency.
Baudouin C; Galarreta DJ; Mrukwa-Kominek E; Böhringer D; Maurino V; Guillon M; Rossi GC; Van der Meulen IJ; Ogundele A; Labetoulle M
Eur J Ophthalmol; 2017 Mar; 27(2):122-128. PubMed ID: 27791253
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of a fixed combination of 0.09 % xanthan gum/0.1 % chondroitin sulfate preservative free vs polyethylene glycol/propylene glycol in subjects with dry eye disease: a multicenter randomized controlled trial.
Pérez-Balbuena AL; Ochoa-Tabares JC; Belalcazar-Rey S; Urzúa-Salinas C; Saucedo-Rodríguez LR; Velasco-Ramos R; Suárez-Sánchez RG; Rodríguez-Carrizalez AD; Oregón-Miranda AA
BMC Ophthalmol; 2016 Sep; 16(1):164. PubMed ID: 27645318
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of a cationic emulsion in the treatment of moderate to severe dry eye disease: a randomized controlled study.
Robert PY; Cochener B; Amrane M; Ismail D; Garrigue JS; Pisella PJ; Baudouin C
Eur J Ophthalmol; 2016 Nov; 26(6):546-555. PubMed ID: 27515572
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the Efficacy of Carboxymethylcellulose 0.5%, Hydroxypropyl-guar Containing Polyethylene Glycol 400/Propylene Glycol, and Hydroxypropyl Methyl Cellulose 0.3% Tear Substitutes in Improving Ocular Surface Disease Index in Cases of Dry Eye.
Maharana PK; Raghuwanshi S; Chauhan AK; Rai VG; Pattebahadur R
Middle East Afr J Ophthalmol; 2017; 24(4):202-206. PubMed ID: 29422755
[TBL] [Abstract][Full Text] [Related]
11. Can the optimum artificial tear treatment for dry eye disease be predicted from presenting signs and symptoms?
Essa L; Laughton D; Wolffsohn JS
Cont Lens Anterior Eye; 2018 Feb; 41(1):60-68. PubMed ID: 28811095
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Tear Supplementation with 0.15% Preservative-Free Zinc-Hyaluronate on Ocular Surface Sensations in Patients with Dry Eye.
Perényi K; Dienes L; Kornafeld A; Kovács B; Kiss HJ; Szepessy Z; Nagy ZZ; Barsi Á; Acosta MC; Gallar J; Kovács I
J Ocul Pharmacol Ther; 2017; 33(6):487-492. PubMed ID: 28375789
[TBL] [Abstract][Full Text] [Related]
13. Targeted delivery of hyaluronic acid to the ocular surface by a polymer-peptide conjugate system for dry eye disease.
Lee D; Lu Q; Sommerfeld SD; Chan A; Menon NG; Schmidt TA; Elisseeff JH; Singh A
Acta Biomater; 2017 Jun; 55():163-171. PubMed ID: 28363785
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Carboxymethylcellulose and Hyaluronate in Dry Eye Disease: A Systematic Review and Meta-Analysis.
Song JK; Lee K; Park HY; Hyon JY; Oh SW; Bae WK; Han JS; Jung SY; Um YJ; Lee GH; Yang JH
Korean J Fam Med; 2017 Jan; 38(1):2-7. PubMed ID: 28197326
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of polyethylene glycol-propylene glycol-based lubricant eye drops in reducing squamous metaplasia in patients with dry eye disease.
Aguilar A; Berra M; Trédicce J; Berra A
Clin Ophthalmol; 2018; 12():1237-1243. PubMed ID: 30034217
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of an enhanced viscosity artificial tear for moderate to severe dry eye disease: A multicenter, double-masked, randomized 30-day study.
Lievens C; Berdy G; Douglass D; Montaquila S; Lin H; Simmons P; Carlisle-Wilcox C; Vehige J; Haque S
Cont Lens Anterior Eye; 2019 Aug; 42(4):443-449. PubMed ID: 30573298
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of dual-polymer hydroxypropyl guar- and hyaluronic acid-containing lubricant eyedrops for the management of dry-eye disease: a randomized double-masked clinical study.
Labetoulle M; Schmickler S; Galarreta D; Böhringer D; Ogundele A; Guillon M; Baudouin C
Clin Ophthalmol; 2018; 12():2499-2508. PubMed ID: 30584269
[TBL] [Abstract][Full Text] [Related]
18. Clinical Outcomes of Fixed Versus As-Needed Use of Artificial Tears in Dry Eye Disease: A 6-Week, Observer-Masked Phase 4 Clinical Trial.
Asbell P; Vingrys AJ; Tan J; Ogundele A; Downie LE; Jerkins G; Shettle L
Invest Ophthalmol Vis Sci; 2018 May; 59(6):2275-2280. PubMed ID: 29715369
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
